Jpmorgan Chase & CO Bio N Tech Se Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Bio N Tech Se stock. As of the latest transaction made, Jpmorgan Chase & CO holds 60,156 shares of BNTX stock, worth $6.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,156

Previous 60,156 -0.0%

Holding current value

$6.2 Million

Previous $5.93 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$96.22 - $115.31 $5.62 Million - $6.73 Million	58,384 Added 3294.81%	60,156 $5.93 Million
Q1 2025 May 12, 2025	SELL	$91.06 - $126.88 $757,437 - $1.06 Million	-8,318 Reduced 82.44%	1,772 $161,000
Q4 2024 Feb 12, 2025	SELL	$99.72 - $122.68 $1.66 Million - $2.04 Million	-16,613 Reduced 62.21%	10,090 $1.15 Million
Q3 2024 Dec 26, 2024	SELL	$78.36 - $124.66 $1.8 Million - $2.87 Million	-23,016 Reduced 46.29%	26,703 $3.17 Million
Q3 2024 Nov 08, 2024	SELL	$78.36 - $124.66 $1.8 Million - $2.87 Million	-23,016 Reduced 46.29%	26,703 $3.17 Million

Q2 2024 Dec 26, 2024	BUY	$80.36 - $102.87 $1.85 Million - $2.37 Million	23,016 Added 86.19%	49,719 $4 Million
Q2 2024 Aug 12, 2024	BUY	$80.36 - $102.87 $3.39 Million - $4.33 Million	42,123 Added 554.54%	49,719 $4 Million
Q1 2024 Dec 26, 2024	SELL	$88.96 - $112.35 $1.7 Million - $2.15 Million	-19,107 Reduced 71.55%	7,596 $700,000
Q1 2024 May 10, 2024	SELL	$88.96 - $112.35 $20,549 - $25,952	-231 Reduced 2.95%	7,596 $700,000
Q4 2023 Dec 26, 2024	SELL	$90.91 - $112.75 $1.72 Million - $2.13 Million	-18,876 Reduced 70.69%	7,827 $826,000
Q4 2023 Feb 12, 2024	BUY	$90.91 - $112.75 $641,551 - $795,676	7,057 Added 916.49%	7,827 $826,000
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $15,957 - $20,262	162 Added 26.64%	770 $83,000
Q2 2023 Aug 11, 2023	SELL	$102.58 - $129.66 $2.5 Million - $3.16 Million	-24,347 Reduced 97.56%	608 $65,000
Q1 2023 May 11, 2023	SELL	$122.57 - $153.67 $248,694 - $311,796	-2,029 Reduced 7.52%	24,955 $3.11 Million
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $1.35 Million - $2.11 Million	11,365 Added 72.76%	26,984 $4.05 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $367,887 - $527,723	-2,882 Reduced 15.58%	15,619 $2.11 Million
Q2 2022 Aug 11, 2022	SELL	$123.25 - $186.24 $210,880 - $318,656	-1,711 Reduced 8.47%	18,501 $2.76 Million
Q1 2022 May 11, 2022	SELL	$126.25 - $231.85 $2.39 Million - $4.38 Million	-18,902 Reduced 48.33%	20,212 $3.45 Million
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $672,233 - $1.12 Million	3,103 Added 8.62%	39,114 $10.1 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $7.42 Million - $16.1 Million	36,011 New	36,011 $9.83 Million

Others Institutions Holding BNTX

# of Institutions

319

Shares Held

37.1M

Call Options Held

1.15M

Put Options Held

1.36M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Bio N Tech Se Transaction History